Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease

被引:8
|
作者
Chen, Ching [1 ]
Chang, Ting-Ting [1 ,2 ]
Chen, Jaw-Wen [1 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Dept & Inst Pharmacol, Sch Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Biomed Ind PhD Program, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[4] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
[5] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan
[6] Taipei Med Univ, Taipei, Taiwan
[7] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[8] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
关键词
Chemokine; Cardiovascular disease; Diabetes mellitus; Kidney disease; CXCL5; CHEMOKINE RECEPTORS; PEPTIDE ENA-78; NEUTROPHIL RECRUITMENT; LIGAND; 5; CELLS; EXPRESSION; CYTOKINES; OBESITY; INFLAMMATION; HOMEOSTASIS;
D O I
10.1016/j.lfs.2023.122018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokines, by modulating inflammation process, could contribute to the development of cardiovascular dis-ease, diabetes mellitus (DM), and kidney disease. Chemokine CXC motif ligand 5 (CXCL5) is one of the inducible chemokines that may be involved in various inflammatory diseases. Given the bidirectional promiscuity char-acteristics of the chemokine system, the mechanistic roles of CXCL5 should be further explored in each specific disease. In this article, we sought to review the recent evidence on the differential effects of CXCL5 and their potential mechanisms in cardiovascular disease, DM, and renal disease individually. Future study is still required to verify if CXCL5 could be a novel therapeutic target in these diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults
    Amber L. Beitelshees
    Christina L. Aquilante
    Hooman Allayee
    Taimour Y. Langaee
    Gregory J. Welder
    Richard S. Schofield
    Issam Zineh
    Human Genomics, 6
  • [22] The role of diabetes mellitus and hypertension in chronic kidney disease
    Ghaderian, Seyed Bahman
    Beladi-Mousavi, Seyed Seifollah
    JOURNAL OF RENAL INJURY PREVENTION, 2014, 3 (04): : 109 - 110
  • [23] Risk of Cardiovascular Disease and Chronic Kidney Disease According to 2017 Blood Pressure Categories in Diabetes Mellitus
    Kim, Yong Tae
    Chung, Hyung Joon
    Park, Bo Ram
    Kim, Yeon Yong
    Lee, Jun Hyeok
    Kang, Dae Ryong
    Kim, Jang-Young
    Lee, Mi Young
    Lee, Jun Young
    HYPERTENSION, 2020, 76 (03) : 766 - 775
  • [24] Cardiovascular disease risk in youth with diabetes mellitus
    R. Paul Wadwa
    Reviews in Endocrine and Metabolic Disorders, 2006, 7 : 197 - 204
  • [25] Functional role of gut microbiota and PCSK9 in the pathogenesis of diabetes mellitus and cardiovascular disease
    Morelli, Marco Bruno
    Wang, Xujun
    Santulli, Gaetano
    ATHEROSCLEROSIS, 2019, 289 : 176 - 178
  • [26] Body Fat Distribution, Diabetes Mellitus, and Cardiovascular Disease: an Update
    Kang, Puneet S.
    Neeland, Ian J.
    CURRENT CARDIOLOGY REPORTS, 2023, 25 (11) : 1555 - 1564
  • [27] Diabetes mellitus as cardiovascular disease risk factor
    Constantin, Gianina Ioana
    Opris, Simona
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : S160 - S161
  • [28] CXCL5 inhibition ameliorates acute kidney injury and prevents the progression from acute kidney injury to chronic disease
    Chang, Ting-Ting
    Li, Szu-Yuan
    Tsai, Ming-Tsun
    Chiang, Chih-Hung
    Chen, Ching
    Chen, Jaw-Wen
    CLINICAL SCIENCE, 2024, 138 (22) : 1451 - 1466
  • [29] A history of diabetes mellitus - A disease of the kidneys that became a kidney disease
    Eknoyan, Garabed
    JOURNAL OF NEPHROLOGY, 2006, 19 : S71 - S74
  • [30] Chronic kidney disease in patients with diabetes mellitus
    Nordheim, Espen
    Jenssen, Trond Geir
    ENDOCRINE CONNECTIONS, 2021, 10 (05) : R151 - R159